悦安新材(688786.SH):擬投建高性能軟磁吸波系列粉體材料後處理及研發中心項目
格隆匯1月12日丨悦安新材(688786.SH)公佈,為進一步提升公司高性能軟磁吸波系列粉體材料的綜合性能以及生產製造流程的自動化、智能化水平,增強公司產品研發和產業化能力,滿足軟磁、電子元器件、微波吸收等下游領域對高新技術產品的市場需求,提升公司的整體競爭力和盈利能力。公司全資子公司悦龍新材擬使用自籌資金在江西省贛州經濟技術開發區投資建設高性能軟磁吸波系列粉體材料後處理及研發中心項目。
投資金額不超過1.5億元(最終投資總額以實際投資為準),資金來源為自籌資金。項目建設週期36個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.